Hyperosmolar hyperglycemic state
| Hyperosmolar hyperglycemic state | |
|---|---|
| Synonyms | Hyperosmolar non-ketotic state, Hyperosmolar non-ketotic coma |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Dehydration, confusion, lethargy, seizures |
| Complications | Coma, death |
| Onset | Gradual |
| Duration | Variable |
| Types | N/A |
| Causes | Infection, medication noncompliance, stress |
| Risks | Type 2 diabetes, elderly, chronic illness |
| Diagnosis | Blood test, urinalysis |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | Intravenous fluids, insulin therapy, electrolyte replacement |
| Medication | N/A |
| Prognosis | Variable |
| Frequency | Less common than diabetic ketoacidosis |
| Deaths | N/A |
Hyperosmolar hyperglycemic state (HHS) is a serious complication of diabetes mellitus, particularly type 2 diabetes. It is characterized by extreme hyperglycemia, hyperosmolarity, and dehydration without significant ketoacidosis.
Signs and Symptoms[edit]
The symptoms of HHS include severe dehydration, confusion, lethargy, and in severe cases, seizures and coma. Patients may also experience polyuria and polydipsia.
Causes[edit]
HHS is often precipitated by factors such as infection, medication noncompliance, or stress. It is more common in the elderly and those with chronic illness.
Pathophysiology[edit]
In HHS, the body experiences extreme hyperglycemia due to insufficient insulin action. This leads to increased osmolarity of the blood, causing water to move out of cells and resulting in severe dehydration. Unlike diabetic ketoacidosis, there is minimal ketone production.
Diagnosis[edit]
Diagnosis of HHS is based on clinical presentation and laboratory tests. Key diagnostic criteria include high blood glucose levels, increased serum osmolarity, and absence of significant ketonemia.
Treatment[edit]
The primary treatment for HHS involves aggressive intravenous fluid replacement to correct dehydration, insulin therapy to reduce blood glucose levels, and electrolyte replacement to address imbalances. Monitoring and supportive care are crucial.
Prognosis[edit]
The prognosis of HHS varies depending on the timeliness of treatment and the presence of underlying conditions. Early intervention can significantly improve outcomes.
See Also[edit]
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian